Smallpox pathophysiology: Difference between revisions
Joao Silva (talk | contribs) |
Joao Silva (talk | contribs) |
||
| Line 34: | Line 34: | ||
* [[Kidneys]] | * [[Kidneys]] | ||
Before development of the [[rash]], the first lesions appear on the oropharyngeal mucosa, at which time the virus is released through the mucosal secretions, making that patient infectious. | Before development of the [[rash]], the first lesions appear on the [[oropharyngeal]] [[mucosa]], at which time the [[virus]] is released through the [[mucosal]] secretions, making that patient [[infectious]]. | ||
Skin lesions develop due to migration of macrophages to the infected areas of the dermis, leading to edema and necrosis. With the influx of more polymorphonuclear cells skin pustules will develop.<ref name="MooreSeward2006">{{cite journal|last1=Moore|first1=Zack S|last2=Seward|first2=Jane F|last3=Lane|first3=J Michael|title=Smallpox|journal=The Lancet|volume=367|issue=9508|year=2006|pages=425–435|issn=01406736|doi=10.1016/S0140-6736(06)68143-9}}</ref> | [[Skin lesions]] develop due to migration of [[macrophages]] to the [[infected]] areas of the [[dermis]], leading to [[edema]] and [[necrosis]]. With the influx of more [[polymorphonuclear cells]], [[skin]] [[pustules]] will develop.<ref name="MooreSeward2006">{{cite journal|last1=Moore|first1=Zack S|last2=Seward|first2=Jane F|last3=Lane|first3=J Michael|title=Smallpox|journal=The Lancet|volume=367|issue=9508|year=2006|pages=425–435|issn=01406736|doi=10.1016/S0140-6736(06)68143-9}}</ref> | ||
The [[immune system]] responds to the [[viremia]] with activation of [[lymphocytes]] T and B and concomitant production of:<ref name="BremanHenderson2002">{{cite journal|last1=Breman|first1=Joel G.|last2=Henderson|first2=D.A.|title=Diagnosis and Management of Smallpox|journal=New England Journal of Medicine|volume=346|issue=17|year=2002|pages=1300–1308|issn=0028-4793|doi=10.1056/NEJMra020025}}</ref> | |||
The [[immune system]] responds to the [[viremia]] with activation of lymphocytes T and B and concomitant production of:<ref name="BremanHenderson2002">{{cite journal|last1=Breman|first1=Joel G.|last2=Henderson|first2=D.A.|title=Diagnosis and Management of Smallpox|journal=New England Journal of Medicine|volume=346|issue=17|year=2002|pages=1300–1308|issn=0028-4793|doi=10.1056/NEJMra020025}}</ref> | |||
* Neutralizing [[antibodies]],during first week of disease, remaining for many years. | * Neutralizing [[antibodies]],during first week of disease, remaining for many years. | ||
Revision as of 21:16, 9 July 2014
|
Smallpox Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Smallpox pathophysiology On the Web |
|
American Roentgen Ray Society Images of Smallpox pathophysiology |
|
Risk calculators and risk factors for Smallpox pathophysiology |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Transmission
Smallpox virus is transmitted by:[1]
- Physical contact
- Contact with infected body fluids
- Contact with infected objects
- Air through aerosolized particles
Genetics
Pathogenesis
The smallpox virus commonly enters the body through the upper respiratory tract, invading the oropharyngeal and respiratory mucosa.[2] Other possible ports of entry include: skin, conjunctivae as well as through the placenta.[3] Although the viral scabs may contain life viruses, they are commonly contained within thickened material, which limits transmissibility.
Once in the respiratory mucosa, the infection commonly progresses as:[4][3][5]
- Asymptomatic respiratory mucosa infection
- Viral replication within respiratory epithelium
- Transient primary asymptomatic viraemia
- Virus enters macrophages and spreads to lymph nodes and reticuloendothelial system, where it replicates during 4 - 14 days
- Exuberant secondary viraemia, leading to symptom onset
During secondary viraemia the virus infects mucous cells of the pharynx and mouth, and endothelium of the capillaries of the dermis, causing skin scabs. Other organs with high viral loads include:[5]
Before development of the rash, the first lesions appear on the oropharyngeal mucosa, at which time the virus is released through the mucosal secretions, making that patient infectious.
Skin lesions develop due to migration of macrophages to the infected areas of the dermis, leading to edema and necrosis. With the influx of more polymorphonuclear cells, skin pustules will develop.[4]
The immune system responds to the viremia with activation of lymphocytes T and B and concomitant production of:[5]
- Neutralizing antibodies,during first week of disease, remaining for many years.
- Hemagglutination-inhibition antibodies, by the 16th day of infection, beginning to decrease after 1 year
- Complement-fixation antibodies, by the 18th day of infection, beginning to decrease after 1 year
Associated Conditions
Gross Pathology
Microscopic Pathology
References
- ↑ "Smallpox disease overview".
- ↑ Cecil, Russell (2012). Goldman's Cecil medicine. Philadelphia: Elsevier/Saunders. ISBN 1437716040.
- ↑ 3.0 3.1 "Smallpox and its Eradication" (PDF).
- ↑ 4.0 4.1 Moore, Zack S; Seward, Jane F; Lane, J Michael (2006). "Smallpox". The Lancet. 367 (9508): 425–435. doi:10.1016/S0140-6736(06)68143-9. ISSN 0140-6736.
- ↑ 5.0 5.1 5.2 Breman, Joel G.; Henderson, D.A. (2002). "Diagnosis and Management of Smallpox". New England Journal of Medicine. 346 (17): 1300–1308. doi:10.1056/NEJMra020025. ISSN 0028-4793.